10x Genomics, Inc. (TXG)
Health Care ยท Laboratory Analytical Instruments
10x Genomics, Inc. (TXG) is listed on Nasdaq, where its shares have traded since September 12, 2019. SentiSense covers 10x Genomics, Inc. in the Health Care sector, and its Standard Industrial Classification is Laboratory Analytical Instruments. Serge Saxonov is its chief executive officer. The company reports 1,178 employees, and its corporate website is www.10xgenomics.com.
About 10x Genomics, Inc.
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives operates from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).
Latest reported results
10x Genomics Inc. reported revenue of $150.7 million for Q3 FY2026, up 1.1% from the same period a year earlier.
Institutional ownership
In 13F filings for the quarter ended June 30, 2026, 378 institutions reported holding TXG, with 128.3 million shares worth $4.9 billion in aggregate. The largest reported holders were FMR, Vanguard and BlackRock. Of the 5 largest reported holders, 2 added shares and 3 reduced their positions during the quarter.
More on TXG
- TXG sentiment: whether news and social coverage of 10x Genomics, Inc. leans bullish or bearish, and the stories driving it.
- TXG ownership: all 378 reporting institutions, plus insider and congressional trades.
- TXG financials: revenue, net income, operating margin and free cash flow through Q3 FY2026.
Frequently asked questions
What does 10x Genomics, Inc. do?
10x Genomics Inc is a life science technology company based in the United States.
What sector is TXG in?
SentiSense classifies 10x Genomics, Inc. in the Health Care sector, and its Standard Industrial Classification is Laboratory Analytical Instruments.
Where does TXG stock trade?
10x Genomics, Inc. (TXG) is listed on Nasdaq, where its shares have traded since September 12, 2019.
Who is the CEO of 10x Genomics, Inc.?
Serge Saxonov is the chief executive officer of 10x Genomics, Inc..